Bausch Health Companies Inc. Announces Second-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Bausch Health Companies (BHC) PT Raised to $26 at RBC Capital
August 8, 2018 8:12 AM EDTRBC Capital raised its price target on Bausch Health Companies (NYSE: BHC) to $26.00 (from $25.00) while maintaining a Sector Perform rating.
... MoreBausch Health Companies (BHC) PT Raised to $30 at Deutsche Bank
August 8, 2018 6:32 AM EDTDeutsche Bank raised its price target on Bausch Health Companies (NYSE: BHC) to $30.00 (from $25.00) while maintaining a Buy rating.
Analsyt Gregg Gilbert commented, "BHC reported solid 2Q18 results, with revenue, EBITDA, and EPS coming in above our model (cash flow from ops... More
Bausch Health Companies (BHC) Reports Q2 Revenues of $2.125B; Boosts FY18 Adj. EBITDA Guidance, Offers FY18 Revenue Outlook
August 7, 2018 7:23 AM EDTBausch Health Companies (NYSE: BHC) reported Q2 revenue for the quarter came in at $2.13 billion.
Revenues of $2.128 BillionGAAP Net Loss of $873 MillionGAAP Cash Flow from Operations of $222 MillionAdjusted EBITDA (non-GAAP)1 of $868 MillionDelivered Second Consecutive Quarter of Overall Organic Revenue Growth2, Driven by the Salix... More